Similar articles for PMID: 21917649

Year	Number of Results
1940	1
1950	1
1956	1
1993	5
1994	2
1995	1
1996	3
1997	4
1998	9
1999	3
2000	6
2001	6
2002	5
2003	2
2004	13
2005	8
2006	11
2007	7
2008	6
2009	10
2010	7
2011	9
2012	14
2013	18
2014	13
2015	13
2016	5
2017	7
2018	17
2019	13
2020	15
2021	7
2022	8
2023	4
2024	0

1

Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.

Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J, Lu AP, Xia HH, Lam S, You WC. Wong BC, et al. Gut. 2012 Jun;61(6):812-8. doi: 10.1136/gutjnl-2011-300154. Epub 2011 Sep 13. Gut. 2012. PMID: 21917649 Clinical Trial.

2

Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.

Zhang Y, Pan KF, Zhang L, Ma JL, Zhou T, Li JY, Shen L, You WC. Zhang Y, et al. Carcinogenesis. 2015 Dec;36(12):1572-9. doi: 10.1093/carcin/bgv147. Epub 2015 Oct 7. Carcinogenesis. 2015. PMID: 26449252 Clinical Trial.

3

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF Jr, Xu GW, Gail MH. You WC, et al. J Natl Cancer Inst. 2006 Jul 19;98(14):974-83. doi: 10.1093/jnci/djj264. J Natl Cancer Inst. 2006. PMID: 16849680 Clinical Trial.

4

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group. Wong BC, et al. JAMA. 2004 Jan 14;291(2):187-94. doi: 10.1001/jama.291.2.187. JAMA. 2004. PMID: 14722144 Clinical Trial.

5

[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].

Gisbert JP, Boixeda D, Martín de Argila C, Redondo C, Moreno L, Abraira V, García Plaza A. Gisbert JP, et al. Med Clin (Barc). 1998 Jan 17;110(1):1-5. Med Clin (Barc). 1998. PMID: 9527978 Clinical Trial. Spanish.

6

Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.

Mohar A, Ley C, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J. Mohar A, et al. Am J Gastroenterol. 2002 Oct;97(10):2530-5. doi: 10.1111/j.1572-0241.2002.06035.x. Am J Gastroenterol. 2002. PMID: 12385434 Clinical Trial.

7

[Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].

Martín Mir ML, Val J, Fuentes J, García S, Yus C, Simón MA, Gomollón F. Martín Mir ML, et al. Gastroenterol Hepatol. 1998 Nov;21(9):432-6. Gastroenterol Hepatol. 1998. PMID: 9882932 Clinical Trial. Spanish.

8

Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.

Kikuchi S, Kato M, Katsuyama T, Tominaga S, Asaka M. Kikuchi S, et al. Helicobacter. 2006 Jun;11(3):147-51. doi: 10.1111/j.1523-5378.2006.00392.x. Helicobacter. 2006. PMID: 16684261 Clinical Trial.

9

Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.

Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J. Zhang LJ, et al. World J Gastroenterol. 2009 Jun 14;15(22):2731-8. doi: 10.3748/wjg.15.2731. World J Gastroenterol. 2009. PMID: 19522023 Free PMC article. Clinical Trial.

10

Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.

Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S; Japan Helicobacter pylori Eradication Study Group. Asaka M, et al. J Gastroenterol. 2003;38(4):339-47. doi: 10.1007/s005350300061. J Gastroenterol. 2003. PMID: 12743773 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

236 results

Results by year